BIBLIOGRAPHIC RECORD

Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Luke D. Tyson; Alexandra Cheng; Charles Kelleher; Kirstin Strathie; James Lovendoski; Zebib Habtemariam; Heather Lewis
Source of metadata
Crossref
Year recorded
2021

Public identifiers and source

Open the source record

Reference

Luke D. Tyson; Alexandra Cheng; Charles Kelleher; Kirstin Strathie; James Lovendoski; Zebib Habtemariam; Heather Lewis. (2021). Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice. https://doi.org/10.1097/meg.0000000000002304

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-c0b6239be00d6fd4fabb1ee329ce39a2/